Why Dynavax Technologies Stock Is Soaring Today

12:42pm, Wednesday, 22'nd Sep 2021
A COVID-19 vaccine candidate that employs the company's adjuvant technology produced positive clinical trial results.
Clover Biopharmaceuticals has reported positive data for their COVID-19 vaccine candidate, SCB-2019, which achieved the primary and secondary efficacy endpoints in SPECTRA Phase 2/3 clinical trial.
EMERYVILLE, Calif., Sept. 22, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced tha
Their vaccines could be late to the party. But the stocks might still be big winners.
Saint- Herb lain (Franc e ) , September 14 , 2021 – Valneva SE, a specialty vaccine company, today announced that it has completed recruitment of the initial cohort of elderly participants in Valnev
A lost supply agreement for a partner's COVID-19 vaccine is hurting the biotech's shares today.

Why Dynavax Shares Are Trading Lower Today

10:09am, Monday, 13'th Sep 2021
Dynavax Technologies Corp (NASDAQ: DVAX) is trading lower after the company announced Valneva SE (NASDAQ: VALN) received a termination notice from the United Kingdom government in relation to Valneva

China Crackdown Continues

06:32am, Monday, 13'th Sep 2021
Chinese regulators continue to apply pressure on the country's biggest tech companies, this time reportedly looking to split up Alibaba (NYSE:BABA) founder Jack Ma's Alipay. Beijing is pushing for Ali
EMERYVILLE, Calif., Sept. 13, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced tha
Saint- Herb lain (France ) , September 13 , 2021 – Valneva SE, a specialty vaccine company, today announced that it has received a termination notice from the UK Government (“HMG”) in relation t
One of the company's partners launched its COVID-19 vaccine in Taiwan.

Why Coronavirus Stock Dynavax Crushed It Today

04:22pm, Monday, 23'rd Aug 2021
There was some very good news on the authorization front for the company.
Medigen Vaccine Biologics Corporation and Dynavax Technologies Corporation (NASDAQ: DVAX) announced the rollout of their COVID-19 vaccine, MVC-COV1901, in Taiwan.  Approximately 600,000 people ar
Investors appeared to be rattled by the U.S. government's decision to move forward with booster doses of mRNA vaccines.
The least expensive COVID-19 vaccine stock right now isn't one of the leaders in the market -- at least not yet.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE